New Medicines, Novel Insights: Accelerating development of cell and gene therapies
Cell and gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unprecedented challenges for sponsors. In this report, Parexel experts share insights that can bring these complex treatments to market faster and more efficiently.
Related Insights
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future
May 15, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022
Related Insights
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future
May 15, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Cell & Gene Therapies: A Regulatory Update
Jul 22, 2022